Register and share your invite link to earn from video plays and referrals.

Search results for TYPE_1
TYPE_1 community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including TYPE_1
Type 1 is @thsottiaux. With him something is always about to change everything. Best DevDay in the history of OpenAI, stuff that changes how you work, a new ship every single day, we are cooking. Then you open the daily post and its a disk space fix. Or a cli update. Everyone is disappointed again and after a while ppl just get tired of Type 1. It looks like he needs applause for every little thing Type 2 is Liang Wenfeng. He doesnt even have an X account. The DeepSeek API goes down for hours, they refund a whole week. 2 days later theres a new model sitting in the API before anyone announced anything. They call it a minor update. Same price. Rn its #1# on OpenRouter with more than double the tokens of #2#. GPT-6.1 Sol from DevDay is #10# be like type 2
Show more
Type 1 breakouts usually extend beyond price objective. Once a stock enters into target area (+80% range of price target) without any pullback, you know that you are riding a Type 1 breakout and ideally be patient to remain (either whole or partial) in position to capture more of the upside.
Show more
Type 1 breakout, exceeded its price objective. Now close to technical resistance, forming long upper shadows show sellers are stepping in around resistance. Text-book price actions so far. $BTCUSD
Show more
Patients with narcolepsy type 1 continue to experience residual disease burden despite guideline-recommended therapy However, orexin-targeted therapies are showing promising results in trials... 📈 >> Selective hypocretin receptor agonists, designed to directly restore orexin signalling << 📺 Sleep Medicine expert, Prof. Yves Dauvilliers takes us through the evolution of narcolepsy type 1 care in this case-based animated video Programme endorsed by ANC & Reference Centre for Narcolepsy and Rare Hypersomnias Supported by an Independent Educational Grant from Takeda
Show more
A small clinical trial for people with Type 1 diabetes combined a transplant with an experimental antirejection drug, allowing some patients to stop taking insulin. More research is needed, but experts are cautiously optimistic about the results.
Show more
There were years where overall Type 1 breakouts dropped below historical averages. Even in those years, #rectangle# chart pattern continued to deliver. This is from 2022 where Type 1 overall is around the same as 2026.
Show more
If you or someone you know has type 1 diabetes, Dr Sara discusses the game-changing insulin treatment that adapts to changing blood sugar levels.
Do you or someone you know have Type 1 Diabetes? It's so important to stay on top of your eye appointments! Click to learn more here:
*NSYNC Star Lance Bass, Type 1 Diabetes Advocate, to be Honored at Breakthrough T1D Los Angeles Gala
A Factor Move buy signal was given yesterday via probably Type 1 breakout at 30,537 $NQ_F with target at 33,650